Log In
Print
BCIQ
Print
Print this Print this
 

MSDC-0160 (formerly mitoglitazone)

  Manage Alerts
Collapse Summary General Information
Company Metabolic Solutions Development Co.
Description mTOT modulating insulin sensitizer
Molecular Target Mitochondrial pyruvate carrier 1 (MPC1) (BRP44L) ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMitochondrial target of thiazolidinedione (mTOT) modulator
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today